» Articles » PMID: 39290452

Prevalence and Patterns of Sleep-related Melatonin Usage Among Adults in Saudi Arabia: A Self-reported Cross-sectional National Study

Overview
Journal Saudi Pharm J
Specialty Pharmacy
Date 2024 Sep 18
PMID 39290452
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Despite the surge of melatonin supplement consumption in recent years, data on the prevalence and patterns of melatonin usage in Saudi Arabia is lacking. The aim of this study was to assess the prevalence and pattern of sleep-related melatonin usage among adults in Saudi Arabia.

Methods: This was a cross-sectional, web-based, self-administered survey study conducted across all regions of Saudi Arabia. Participants were recruited from the general population (≥18 years). The survey was distributed between February and April 2023. Chi-squared tests and t-tests were performed for comparative bivariate analyses where binary logistic regression was performed to derive the main predictors of melatonin consumption.

Results: Out of 5,606 participants, 536 (10 %) were consumers of melatonin. Older age (Adjusted OR = 1.01, 95 % CI = 1.01-1.02, p = 0.002), being a male (Adjusted OR = 1.76, 95 % CI = 1.46-2.14, p = 0.001), individuals with a doctorate degree or an equivalent (adjusted OR 2.37 95 % CI = 1.35-4.17, p = 0.003), perceived poor sleep quality (Adjusted OR = 1.52, 95 % CI = 1.10-2.11, p = 0.01), and being diagnosed with a sleep disorder (Adjusted OR = 2.55, 95 % CI = 2.04-3.18, p = 0.001) were all associated with increased likelihood of sleep-related melatonin usage. 35 % of consumers self-reported taking ≥1 tablet per day, while 26 % of them were uncertain about the dosage they consume.

Conclusion: With a notable prevalence of 10% among the general population in Saudi Arabia, melatonin usage was more common in older adults, males, and those with higher education.

References
1.
Costello R, Lentino C, Boyd C, OConnell M, Crawford C, Sprengel M . The effectiveness of melatonin for promoting healthy sleep: a rapid evidence assessment of the literature. Nutr J. 2014; 13:106. PMC: 4273450. DOI: 10.1186/1475-2891-13-106. View

2.
Buscemi N, Vandermeer B, Hooton N, Pandya R, Tjosvold L, Hartling L . The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis. J Gen Intern Med. 2006; 20(12):1151-8. PMC: 1490287. DOI: 10.1111/j.1525-1497.2005.0243.x. View

3.
Carriedo-Diez B, Tosoratto-Venturi J, Canton-Manzano C, Wanden-Berghe C, Sanz-Valero J . The Effects of the Exogenous Melatonin on Shift Work Sleep Disorder in Health Personnel: A Systematic Review. Int J Environ Res Public Health. 2022; 19(16). PMC: 9408537. DOI: 10.3390/ijerph191610199. View

4.
Ferracioli-Oda E, Qawasmi A, Bloch M . Meta-analysis: melatonin for the treatment of primary sleep disorders. PLoS One. 2013; 8(5):e63773. PMC: 3656905. DOI: 10.1371/journal.pone.0063773. View

5.
Bliddal M, Kildegaard H, Rasmussen L, Ernst M, Jennum P, Mogensen S . Melatonin use among children, adolescents, and young adults: a Danish nationwide drug utilization study. Eur Child Adolesc Psychiatry. 2022; 32(10):2021-2029. DOI: 10.1007/s00787-022-02035-1. View